The World Health Organization (WHO) has approved the emergency use of the Pfizer-Bioentech vaccine to prevent coronavirus.
Pfizer's name was added Wednesday as the first vaccine on the agency's approved vaccine list to prevent the virus.
On December 2, the United Kingdom was the first country in the world to approve the use of Pfizer-Bioentech corona vaccine. Then on December 8, the application began.
This decision by the WHO paved the way for the rapid approval of the import and distribution of vaccines worldwide. From now on, Pfizer will discuss various vaccine data with the WHO.
The agency said in a statement that the approval would allow UNICEF and the Pan American Health Agency to be involved in the distribution of vaccines in case of an emergency.
The coronavirus, which was first identified in Wuhan in China's Hubei province in December 2019, is now sweeping the world. All countries are in turmoil. The death toll is also rising.
In such a situation, several tickers have already been applied to prevent corona. Its application is going on in different countries of the world, some countries are waiting for its application.
Countries like Russia, Iran and China are using their own vaccines. However, Pfizer, Oxford and Modern vaccines are the most widely applied.
Meanwhile, one person died after being vaccinated in Luzern, Switzerland. However, it is not yet clear whether the person died as a result of any side effects caused by the vaccine.
Authorities say the vaccine, developed in a joint study by US pharmaceutical company Pfizer and German company Bioentech, is 95 percent effective.
Authorities say the vaccine should be stored at a temperature of minus 70 degrees Celsius. This vaccine should be taken in two doses every three weeks.
